FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, in particular to a composition for correcting dyslipidemia and maintaining the functional state of the human body in the metabolic syndrome. Composition for the correction of dyslipidemia and the maintenance of the functional state of the human body in metabolic syndrome, which included: sterilized lyophilized culture fluid obtained by cultivating the VKPM №B-2335 Bacillus subtilis probiotic bacterial strain and containing metabolites of bacilli, zeolite, calcium stearate, resveratrol, coenzyme Q10, α-tocopherol acetate, lactose, a complex of enzymes containing alpha-amylase, neutral and alkaline proteinases, beta-glucanase, cellulase, xylanase, and silicon dioxide at a certain ratio of components, the composition is made in solid form in the form of granules, capsules or sachets.
EFFECT: above invention allows to expand the range of tools for the correction of dyslipidemia and maintain the functional state of the human body in the metabolic syndrome.
1 cl, 26 tbl, 2 dwg, 6 ex
